Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Novel Discovery In Dendritic Cell Signalling Pathways Pave The Way For New Therapeutic Targets
Scientists from A*STAR"s Singapore Immunology Network (SIgN) and the University of Milano-Bicocca, Italy, have discovered another signaling pathway for the activation and apoptosis, or programmed cell death, of dendritic cells[1] . This discovery was published in the advanced online publication of Nature on 15 Jun 2009.
generic viagra online
Editorial Discusses Removal Of Needle Exchange Funding Ban
A Wilmington News Journal editorial discussed the potential lifting of the ban on using federal funding for needle exchange programs. The editorial notes recent Congressional action and the restrictions in a House bill that prohibit needle exchanges to operate "within a 1,000 feet of day care centers, schools, parks, playgrounds, pools and youth centers." According to the News Journal, "This rule wipes out much of the flexibility many cities need in their fight to prevent the spread of HIV among intravenous drug users. The nation"s capital, where the rates of HIV and AIDS cases are considered epidemic, would be hit the hardest because no part of the District of Columbia would be eligible for the funding according to AIDS Action." The editorial adds, "Vans patrolling near vulnerable populations - specifically young, impressionable children - are an issue that must be addressed. But well-intentioned limits should not be allowed to hold up the rest of the program," according to the News Journal (8/1).
News of the day
UCLA Scientists Identify How Immune Cells May Help Predict Alzheimer's Risk; MP Biomedicals Granted Rights To Further Develop Screening Tool
UCLA scientists have discovered a way to measure the amount of amyloid beta that is being absorbed by immune cells in the blood. Amyloid beta forms the plaques considered the hallmark of Alzheimer"s disease, and if the immune system isn"t adequately clearing amyloid beta, it may indicate Alzheimer"s risk, according to the researchers.
Health Insurance

FDA Warns Consumers Not To Buy Or Use Hardcore Energize Bullet Or New Whey Liquid Products

The U.S. Food and Drug Administration is warning consumers not to buy or use Hardcore Energize Bullet or New Whey liquid products sold in test tube-like vials due to suspected product tampering. The products are being recalled. The suspected tampering involved a utility knife blade found in one vial of Hardcore Energize Bullet drink, manufactured in the United States and sold in Canada, and another blade in one vial of New Whey liquid products, manufactured and sold in the United States. No one is known to have been hurt. Hardcore Energize Bullet and New Whey liquid products are manufactured by Protica Inc., of Whitehall, Pa. Protica is investigating this incident. Hardcore Energize Bullet liquid products were distributed in Canada and are being recalled by iSatori Technologies of Golden, Colo. The liquid is packaged in 2.9 ounce clear, test-tube like vials and in two flavors, Blue Rage and Black Rush. The affected lots for the Blue Rage liquid product are: 1961, 1962, and 1794. The affected lot for the Black Rush liquid product is 1963. New Whey liquid products were distributed and are being recalled by IDS of Oviedo, Fla. and were sold at various retail stores. The liquid is packaged in 2.9 ounce clear, test-tube like vials and two flavors, New Whey Fruit Punch 25g and New Whey Blue Raspberry 42g. The affected lot for the New Whey Fruit Punch liquid product is 1960. The affected lot for the New Whey Blue Raspberry liquid product is 1944. The FDA advises consumers who may have purchased these products not to consume them. Health care professionals and consumers are encouraged to report serious adverse effects or product quality problems with the use of Hardcore Energize Bullet and New Whey liquid products to the FDA"s MedWatch Adverse Event Reporting program online, by regular mail, fax or phone. - Online - Regular Mail: Use FDA postage paid form 3500 and mail to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787 - Fax: 800-FDA-0178 - Phone: 800-FDA-1088 U.S. Food and Drug Administration


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009